$1.14 +0.17 (%) Echo Therapeutics Inc - NASDAQ

Sep. 19, 2014 | 04:00 PM

Partner Headlines

  1. Echo Therapeutics Mails Letter to Shareholders; Urges Not to Vote Platinum's Gold Proxy Card

    Benzinga | Apr. 29, 2014 | 16:36PM EST
  2. Echo Therapeutics Comments on Proxy Contest by Platinum Management (NY) LLC

    Benzinga | Apr. 22, 2014 | 17:31PM EST
  3. Platinum Management (NY) LLC Urges Stockholders to Take No Action Regarding Echo's May 20th Annual Meeting Until Platinum's Proxy Statement and GOLD Proxy Card Arrive

    Benzinga | Apr. 21, 2014 | 10:38AM EST
  4. Echo Therapeutics Submits CE Mark Technical File to European Notified Body for Symphony CGM System

    Benzinga | Jan. 13, 2014 | 08:56AM EST
  5. Morning Market Losers

    Benzinga | Dec. 3, 2013 | 10:00AM EST
  6. Morning Market Movers

    Benzinga | Oct. 10, 2013 | 09:56AM EST
  7. Echo Therapeutics Schedules Meeting with Platinum-Montaur Next Week, Still Considering Licenses

    Benzinga | Sep. 5, 2013 | 07:51AM EST
  8. Echo Therapeutics Announces CEO, President and Chairman, Dr. Patrick Mooney is Taking Leave of Absense

    Benzinga | Aug. 26, 2013 | 06:53AM EST
  9. LifeTech Capital Reiterates Neutral Rating on Echo Therapeutics Following Q2 Results

    Benzinga | Aug. 19, 2013 | 12:12PM EST
  10. Echo Therapeutics Prices 13.33M Share Offering @ $0.75/Share

    Benzinga | Jan. 31, 2013 | 22:57PM EST
  11. Echo Therapeutics to Report Trial Results of Symphony tCGM System at Critical Care Congress

    Benzinga | Jan. 22, 2013 | 00:51AM EST
  12. Echo Therapeutics Prices 3.2M Share Offering @$0.95/Share

    Benzinga | Dec. 20, 2012 | 15:24PM EST
  13. Stocks Hitting 52-Week Lows

    Benzinga | Dec. 11, 2012 | 03:09AM EST
  14. Stocks Hitting 52-Week Lows

    Benzinga | Dec. 4, 2012 | 03:13AM EST
  15. Echo Therapeutics Announces Proposed Public Offering

    Benzinga | Nov. 27, 2012 | 09:16AM EST
  16. Echo Therapeutics Announces $20 Million Financing with Platinum-Montaur Life Sciences

    Benzinga | Aug. 9, 2012 | 02:04AM EST
  17. Benzinga's Top Initiations

    Benzinga | Aug. 6, 2012 | 01:26AM EST
  18. Echo Therapeutics Announces Positive Clinical Trial Results of Symphony® tCGM System

    Benzinga | Aug. 1, 2012 | 01:50AM EST
  19. UPDATE: Wunderlich Securities Initiates Coverage of Echo Therapeutics with Hold Rating, $1.75 PT

    Benzinga | Jul. 13, 2012 | 03:50AM EST
  20. Echo Therapeutics Expands License Agreement with Ferndale Pharma

    Benzinga | Jul. 11, 2012 | 02:05AM EST
  21. Echo Therapeutics Presents Positive Clinical Trial Results of the Symphony tCGM System at the American Diabetes Association's 72nd Scientific Sessions

    Benzinga | Jun. 12, 2012 | 02:08AM EST
  22. Benzinga's Top Downgrades With Color for May 14, 2012

    Benzinga | May. 14, 2012 | 06:41AM EST
  23. Echo Therapeutics Announces Positive Clinical Trial Results of Symphony® tCGM System

    Benzinga | May. 2, 2012 | 02:10AM EST
  24. Echo Therapeutics Initiates Clinical Trials of its Symphony tCGM System in Critical Care Patients

    Benzinga | Jan. 24, 2012 | 01:16AM EST
  25. LifeTech Has Strong Speculative Buy, $6 PT On Echo Therapeutics

    Benzinga | Dec. 31, 0000 | 19:00PM EST
Trading Center